Successful lithium carbonate treatment for steroid-induced depression following bone marrow transplantation: A case report

N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

Drug-induced mental disturbances are frequent in bone marrow transplantation (BMT) patients who require numerous kinds of drugs. Although steroid-induced mental disorder is common in BMT settings, its treatment has not been fully investigated. We encountered a patient with acute myeloid leukemia who developed depressive disorder induced by steroid given for graft-versus-host disease treatment. Lithium carbonate was effective for the treatment of depressive disorder without causing side effects such as renal dysfunction. This study demonstrates the effectiveness of lithium carbonate for the treatment of depressive disorder induced by steroids in BMT settings. © 2003 Foundation for Promotion of Cancer Research.

Cite

CITATION STYLE

APA

Ito, M., Onose, M., Yamada, T., Onishi, H., Fujisawa, S., & Kanamori, H. (2003). Successful lithium carbonate treatment for steroid-induced depression following bone marrow transplantation: A case report. Japanese Journal of Clinical Oncology, 33(10), 538–540. https://doi.org/10.1093/jjco/hyg097

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free